Motiv8 Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$973K Buy
905
+98
+12% +$93.7K 0.53% 59
2025
Q3
$616K Buy
807
+24
+3% +$17.9K 0.33% 71
2025
Q2
$611K Sell
783
-3
-0.4% -$2.33K 0.37% 72
2025
Q1
$649K Hold
786
0.43% 71
2024
Q4
$607K Hold
786
0.43% 70
2024
Q3
$697K Sell
786
-901
-53% -$810K 0.47% 69
2024
Q2
$1.53M Buy
1,687
+10
+0.6% +$8K 1.14% 24
2024
Q1
$1.3M Sell
1,677
-134
-7% -$95.4K 1.01% 26
2023
Q4
$1.06M Buy
+1,811
New +$1.06M 0.94% 26

Other funds holding LLY

Motiv8 Investments's LLY Position: Q4 2025 in Review

Motiv8 Investments increased its Eli Lilly (LLY) stake by 12% in Q4 2025, buying an estimated $93.7K and bringing the position to 905 shares worth $973K. The position accounts for 0.53% of the portfolio, ranked #59.

Motiv8 Investments first reported a position in LLY in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.53M in Q2 2024. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Motiv8 Investments held 905 shares of Eli Lilly worth $973K as of Q4 2025.
  • Motiv8 Investments bought 98 Eli Lilly shares in Q4 2025, an estimated $93.7K.
  • Eli Lilly made up 0.53% of Motiv8 Investments's portfolio in Q4 2025, its #59 holding.
  • Motiv8 Investments first reported a position in Eli Lilly in Q4 2023 and has held it in 9 quarters since.
  • Motiv8 Investments's Eli Lilly position peaked at $1.53M in Q2 2024.
  • 4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.